<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8A9D6B9D-FD50-4018-8B78-9B31272D3775"><gtr:id>8A9D6B9D-FD50-4018-8B78-9B31272D3775</gtr:id><gtr:firstName>Victoria</gtr:firstName><gtr:surname>Ewan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800440"><gtr:id>FBAB0747-1EA5-4E1D-9EEF-66D96A81BF32</gtr:id><gtr:title>Exploring the link between oral bacterial flora and hospital acquired pneumonia using a novel screening assay.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800440</gtr:grantReference><gtr:abstractText>When people become ill and are admitted to hospital, different bacteria, which can cause chest infections, are found in their mouths. Some, but not all, then develop chest infections. Up to 40% of people may die from chest infections in hospital. These bacteria probably cause chest infections by travelling down from the mouth into the lungs silently. It might be that larger numbers of bacteria lead a chest infection. 

Newer scientific techniques may identify bacteria better and more rapidly than traditional ways. I will design a test for bacteria which cause chest infections in hospital using a scientific technique called real-time multiplex PCR. I will use the test on throat swabs taken from hospital patients who have broken their hips to see how many harbour these bacteria. Then I will follow these patients to find out whether having certain bacteria in the throat puts people at higher risk of getting chest infections in hospital.

This information could help unravel why people develop chest infections in hospital and to help decide what could be done to stop this happening.</gtr:abstractText><gtr:technicalSummary>Translational research in an ageing population is now recognised as being of the utmost importance. This project which is hosted by the Biomedical Research Centre, addresses one important cause of mortality in ageing people, that of hospital acquired pneumonia (HAP). HAP is common and carries an unacceptable mortality of up to 40% 1-3 in older people. Currently it is difficult to predict which patients will develop HAP. After hospitalisation or illness, the oral cavity becomes colonised with bacteria known to cause HAP. While these bacteria are rarely present (0-6%) in healthy adults5, they are seen in 14-40% of hospitalised or institutionalised older people6 7. It is proposed that HAP develops secondary to silent aspiration of these bacteria into the lungs. Evidence suggests that HAP may be preventable by reducing the number of oral bacteria via rigorous oral hygiene9, even in frail patients. As yet, few cohort studies have been undertaken to link oral HAP pathogens with subsequent development of pneumonia.

Objectives
1. Develop an assay to detect prevalent bacterial pathogens in HAP.
2. Define the prevalence of HAP pathogens in the throats of patients with new hip fracture admitted to the acute orthopaedic unit in Newcastle using the assay.
3. Describe the incidence of acquisition within the first 14 days of admission of HAP pathogens in the throats of patients whom were not carriers on admission.
4. Explore whether either presence or high numbers of respiratory bacteria in the throats of these patients within the first 14 days of admission is associated with subsequent development of HAP.

Design 
Development of screening assay, followed by cohort study.

Methodology
Phase 1. Development and validation of real-time multiplex PCR assay.

Phase 2. A cohort of hip fracture patients will be screened for oropharyngeal carriage of HAP bacteria within 14 days of admission using the assay. Cases of HAP will be detected up to three months post discharge. Plaque scores and other oral hygiene indices will also be assessed.

Scientific and medical opportunities of the study
This study will give detailed information regarding the biological gradient of exposure and define antecedent exposure among cases. The anticipated outcome is that patients at high risk of developing HAP may be identified and targeted early in admission for preventative strategies including improving oral hygiene. Preventing pneumonia is likely to reduce morbidity and mortality, and may lead to savings in health care costs 10.</gtr:technicalSummary><gtr:fund><gtr:end>2013-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>195325</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Blizard Institute</gtr:department><gtr:description>Oral microbiome</gtr:description><gtr:id>E912F9FD-E136-41D3-86A5-ABFBC91D9D6A</gtr:id><gtr:impact>None yet- data only just available</gtr:impact><gtr:outcomeId>iVMyCEs9pBr-1</gtr:outcomeId><gtr:partnerContribution>Analysed the results and teaching of analysis/interpretation, will edit manuscripts for publication resulting from this work.</gtr:partnerContribution><gtr:piContribution>Initiated contact, supplied samples and patient database and funds for 454 sequencing of samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Probus Club, Newcastle upon Tyne</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>EC470F4C-9CE4-4F6B-9672-BDD107D3204A</gtr:id><gtr:impact>25 retired business persons from the Newcastle upon Tyne area

Interested discussion.</gtr:impact><gtr:outcomeId>rFkwhdvbQ7Z</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centenary award</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3F9DBD52-880C-4084-AACB-A7863C126ED6</gtr:id><gtr:outcomeId>CD9fbsgHdKQ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Travel Grant for Scientific Excellence</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>International Association for Dental Research (IADR)</gtr:fundingOrg><gtr:id>FFCAE05F-E8C1-4112-9ECB-77C627A8F37A</gtr:id><gtr:outcomeId>5460ba2ec407e4.18994325</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EUGMS Dysphagia working group</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>117690EE-2321-4E0A-8D2A-50B482805F68</gtr:id><gtr:outcomeId>WptC6UAxdTA</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Series of up to 5 tongue/throat swabs from patients with hip fracture over first 14 days of admission</gtr:description><gtr:id>831BAD7F-9079-41EB-9C14-98C222817F8E</gtr:id><gtr:impact>Not analysed yet but first series of it's kind that we're aware of.</gtr:impact><gtr:outcomeId>01FB2F49FFA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Oral swab series</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database of 93 orthopaedic patients with lower limb fracture containing baseline demographic data, results from respiratory bacterial PCR assay (8 respiratory bacterial pathogens) on 14 day swab series, dental data (2-3 plaque scores plus other dental variables), complications arising through the hospital stay and follow up data to 90 days (death, antibiotics for chest infection).</gtr:description><gtr:id>43FA18A3-1F6A-4965-815C-BF7075E18C8F</gtr:id><gtr:impact>Currently working on analysing data using a modelling approach via collaboration with researchers within Biology at Newcastle university.</gtr:impact><gtr:outcomeId>n6gs18dJbex</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Oral flora database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Real time multiplex PCR assay which tests for S. aureus, MRSA, E. coli, Haemophilus influenzae, S. pneumoniae, P. aeurginosa, Acinetobacter, gap (human gene) and a pan-coliform assay (KP16s)</gtr:description><gtr:id>DA20500C-4F66-4D6E-B1F5-8D397AEF8A28</gtr:id><gtr:impact>Results from analysing oral swabs being interpreted in light of clinical data at present. Currently working on outputs- publications anticipated.</gtr:impact><gtr:outcomeId>g791UPjkk8U</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Respibact PCR assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>634FE499-3A49-4559-BE1F-75D185763937</gtr:id><gtr:title>Pneumonia and influenza - specific considerations in care homes</gtr:title><gtr:parentPublicationTitle>Reviews in Clinical Gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/853785ae4c1c85290b595735f2b483ce"><gtr:id>853785ae4c1c85290b595735f2b483ce</gtr:id><gtr:otherNames>Gordon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5460a9b67ecb74.17169145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63D6D8FD-ED86-42AD-BEF8-62FCCE1BAC21</gtr:id><gtr:title>Hospital-acquired pneumonia surveillance-an unmet need.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1770d47684fbfcce7cc99043e35c4c7c"><gtr:id>1770d47684fbfcce7cc99043e35c4c7c</gtr:id><gtr:otherNames>Ewan VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>5aa67a3ce7bb12.69872642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E925689-38E3-49C2-BCF1-C0EF5EF9DA12</gtr:id><gtr:title>Respiratory</gtr:title><gtr:parentPublicationTitle>Age and Ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1f60e0234a11f1e8c7501c40b189e3"><gtr:id>bb1f60e0234a11f1e8c7501c40b189e3</gtr:id><gtr:otherNames>Ewan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5460b03872a1a9.89255383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A74DAB1C-4666-4723-8818-ED2433C94CDA</gtr:id><gtr:title>Oxford Desk Reference- Geriatric Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1f60e0234a11f1e8c7501c40b189e3"><gtr:id>bb1f60e0234a11f1e8c7501c40b189e3</gtr:id><gtr:otherNames>Ewan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-0-19-959234-0</gtr:isbn><gtr:outcomeId>5460a923665982.80810542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A5BE7C8-F112-4337-B5E7-07D47CCB0BE2</gtr:id><gtr:title>Oropharyngeal Microbiota in Frail Older Patients Unaffected by Time in Hospital</gtr:title><gtr:parentPublicationTitle>Frontiers in Cellular and Infection Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1f60e0234a11f1e8c7501c40b189e3"><gtr:id>bb1f60e0234a11f1e8c7501c40b189e3</gtr:id><gtr:otherNames>Ewan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a995f3e6931e8.89313697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F68770B-65F7-43B0-89C8-014B5EB31234</gtr:id><gtr:title>Other medical conditions</gtr:title><gtr:parentPublicationTitle>Age and Ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2cac655be20e91b42129ffc0b189756"><gtr:id>e2cac655be20e91b42129ffc0b189756</gtr:id><gtr:otherNames>McDonald C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5460b468399bf1.04971507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>536A875A-F625-43D9-9BB2-24A0A5257865</gtr:id><gtr:title>Non-respiratory infections - specific considerations in care homes</gtr:title><gtr:parentPublicationTitle>Reviews in Clinical Gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1f60e0234a11f1e8c7501c40b189e3"><gtr:id>bb1f60e0234a11f1e8c7501c40b189e3</gtr:id><gtr:otherNames>Ewan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5460aa3ce5f7c0.56062655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6613C48-0B93-4934-B63F-7D12F09D116C</gtr:id><gtr:title>New horizons in hospital acquired pneumonia in older people.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1f60e0234a11f1e8c7501c40b189e3"><gtr:id>bb1f60e0234a11f1e8c7501c40b189e3</gtr:id><gtr:otherNames>Ewan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>5aa67aa57713e4.52449499</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E625257-1097-40B4-AFD3-03EA292ABAC5</gtr:id><gtr:title>Dental and microbiological risk factors for hospital-acquired pneumonia in non-ventilated older patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1770d47684fbfcce7cc99043e35c4c7c"><gtr:id>1770d47684fbfcce7cc99043e35c4c7c</gtr:id><gtr:otherNames>Ewan VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e3721c043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2A80A58-4114-4CE6-BFEA-1D32743AFCDB</gtr:id><gtr:title>Oral hygiene of hospitalised older patients with lower limb fracture.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1f60e0234a11f1e8c7501c40b189e3"><gtr:id>bb1f60e0234a11f1e8c7501c40b189e3</gtr:id><gtr:otherNames>Ewan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>58b49317181f48.40743986</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800440</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>